Conference Call with Kiri Industries Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Kiri Industries announced Q3FY25 results Consolidated revenues were Rs 281.25 crore, reflecting an 27% YoY growth and a 3% QoQ rise. Consolidated EBIDTA for Q3FY25 was Rs -8.39 crore reflecting negative earnings by 2.8% QoQ due to higher expenditure towards legal fees pertaining to DyStar Case. Kiri’s standalone revenue for Q3FY25 was Rs156.38 crore marking an increase by 8% YoY and 11% QoQ. The Standalone EBIDTA for Q3FY25 was positive Rs 37.40 crore. Result PDF